[HTML][HTML] Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
…, Z Yu, M Fang, T Yu, Y Wang, S Pan, X Zou… - The lancet respiratory …, 2020 - thelancet.com
Background An ongoing outbreak of pneumonia associated with the severe acute respiratory
coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information …
coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information …
Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019
X Zou, S Li, M Fang, M Hu, Y Bian, J Ling… - Critical care …, 2020 - journals.lww.com
Objectives: Coronavirus disease 2019 has emerged as a major global health threat with a
great number of deaths in China. We aimed to assess the association between Acute …
great number of deaths in China. We aimed to assess the association between Acute …
Plasma proteomics identify biomarkers and pathogenesis of COVID-19
T Shu, W Ning, D Wu, J Xu, Q Han, M Huang, X Zou… - Immunity, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis. However,
little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled …
little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled …
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
Background The global numbers of confirmed cases and deceased critically ill patients with
COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its …
COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its …
Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV coinfection
X Zou, M Fang, S Li, L Wu, B Gao, H Gao, X Ran… - Clinical …, 2021 - Elsevier
Background & Aims Coronavirus disease 2019 (COVID-19) is a major global health threat.
We aimed to describe the characteristics of liver function in patients with SARS-CoV-2 and …
We aimed to describe the characteristics of liver function in patients with SARS-CoV-2 and …
The evidence of SARS-CoV-2 infection on ocular surface
X Zhang, X Chen, L Chen, C Deng, X Zou, W Liu, H Yu… - The ocular …, 2020 - Elsevier
This is a cross-sectional study of patients who received a COVID-19 diagnosis between
December 30, 2019 and February 7, 2020 at Tongji Hospital. A total of 102 patients (48 Male [47…
December 30, 2019 and February 7, 2020 at Tongji Hospital. A total of 102 patients (48 Male [47…
The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study
X Zhang, X Chen, L Chen, C Deng, X Zou, W Liu, H Yu… - MedRxiv, 2020 - medrxiv.org
Purpose The aim of this study was to identify whether SARS-COV-2 infected in ocular
surface. Methods Cross-sectional study of patients presenting for who received a COVID-19 …
surface. Methods Cross-sectional study of patients presenting for who received a COVID-19 …
Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p
M Qu, X Zou, F Fang, S Wang, L Xu, Q Zeng… - Nature …, 2020 - nature.com
Thrombosis leads to platelet activation and subsequent degradation; therefore, replenishment
of platelets from hematopoietic stem/progenitor cells (HSPCs) is needed to maintain the …
of platelets from hematopoietic stem/progenitor cells (HSPCs) is needed to maintain the …
[PDF][PDF] NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-κB-NFAT5 complex during septic immunosuppression
Impairment of innate immune cell function and metabolism underlies immunosuppression in
sepsis; however, a promising therapy to orchestrate this impairment is currently lacking. In …
sepsis; however, a promising therapy to orchestrate this impairment is currently lacking. In …
A novel risk-stratification models of the high-flow nasal cannula therapy in COVID-19 patients with hypoxemic respiratory failure
Background: High-flow nasal cannula (HFNC) has been recommended as a suitable choice
for the management of coronavirus disease 2019 (COVID-19) patients with acute …
for the management of coronavirus disease 2019 (COVID-19) patients with acute …